Docetaxel, cisplatin, and 5-fluorouracil compared with epirubicin, cisplatin, and 5-fluorouracil regimen for advanced gastric cancer: A systematic review and meta-analysis

BACKGROUND: As the first-line regimens for the treatment of advanced gastric cancer, both docetaxel, cisplatin, and 5-fluorouracil (DCF) and epirubicin, cisplatin, and 5-fluorouracil (ECF) regimens are commonly used in clinical practice, but there is still controversy about which is better. AIM: To...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Bo, Chen, Lian, Luo, Hong-Liang, Yi, Feng-Ming, Wei, Yi-Ping, Zhang, Wen-Xiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406203/
https://www.ncbi.nlm.nih.gov/pubmed/30863759
http://dx.doi.org/10.12998/wjcc.v7.i5.600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406203/
https://www.ncbi.nlm.nih.gov/pubmed/30863759
http://dx.doi.org/10.12998/wjcc.v7.i5.600

Ejemplares similares